2018•Scandinavian Journal of Infectious DiseasesRequires access

Commercialized fecal microbiota transplantation provides efficacious treatment of Clostridium difficile infection

Chad Martinez, Jonathan Edwards, Ali Hassoun

Abstract

Sir,Research on fecal microbiota transplantation[FMT] has yielded high cure rates for recurrent Clostridium difficile infection. Moreover, as recently described in the present journal, microbiota t...

About this research paper

What this paper is about

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Fecal bacteriotherapy, Clostridium difficile, Medicine, Feces, Clostridium Infections, C difficile, Transplantation, Microbiology

Back to paper search Browse research topics Original source

Commercialized fecal microbiota transplantation provides efficacious treatment of Clostridium difficile infection — Research Paper | ScholarLens